Distinguishing intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma using precontrast and gadoxetic acid-enhanced MRI

scientific article published on March 2015

Distinguishing intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma using precontrast and gadoxetic acid-enhanced MRI is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.5152/DIR.2014.13013
P932PMC publication ID4463313
P698PubMed publication ID25698097
P5875ResearchGate publication ID272518471

P50authorTakashi YoshiuraQ88110055
Kousei IshigamiQ88561938
Yoshiki AsayamaQ88575700
H HondaQ88632968
Akihiro NishieQ89914901
Nobuhiro FujitaQ91958797
Shinichi AishimaQ91965681
Yasuhiro UshijimaQ102145028
Ken ShirabeQ114433176
Yukihisa TakayamaQ114440705
Yuichiro KuboQ117226366
P2860cites workPotential for differential diagnosis with gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging in experimental hepatic tumorsQ30889007
Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengthsQ31011793
Cholangiocarcinoma: morphologic classification according to growth pattern and imaging findingsQ33967898
1.5 tesla magnetic resonance imaging scanners compared with 3.0 tesla magnetic resonance imaging scanners: systematic review of clinical effectivenessQ36234974
Delayed-phase dynamic CT enhancement as a prognostic factor for mass-forming intrahepatic cholangiocarcinomaQ36320113
Hepatocellular carcinoma with a pseudocapsule on gadolinium-enhanced MR images: correlation with histopathologic findingsQ37354633
Consensus report of the 2nd International Forum for Liver MRI.Q37620213
Gadoxetate disodium-enhanced MRI of the liver: part 1, protocol optimization and lesion appearance in the noncirrhotic liver.Q37766703
Intrahepatic mass-forming cholangiocarcinoma: enhancement patterns on gadoxetic acid-enhanced MR images.Q38026533
Cholangiocarcinoma: delayed CT contrast enhancement patternsQ41448248
"Pseudo washout" sign in high-flow hepatic hemangioma on gadoxetic acid contrast-enhanced MRI mimicking hypervascular tumorQ43236786
Gadolinium-ethoxybenzyl-DTPA, a new liver-specific magnetic resonance contrast agent. Kinetic and enhancement patterns in normal and cholestatic ratsQ46213238
Uptake of Gd-EOB-DTPA by hepatocellular carcinoma: radiologic-pathologic correlation with special reference to bile production.Q50533500
Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary systemQ53026443
Arterial blood supply of hepatocellular carcinoma and histologic grading: radiologic-pathologic correlation.Q53445917
Adenomatous hyperplasia in the vicinity of small hepatocellular carcinomaQ67487811
The general rules for the clinical and pathological study of primary liver cancer. Liver Cancer Study Group of JapanQ69507027
CT of hepatic masses: significance of prolonged and delayed enhancementQ70131505
MR imaging of intrahepatic cholangiocarcinoma with pathologic correlationQ73927764
Pathomorphologic study on the mechanism of fatty change in small hepatocellular carcinoma of humansQ74203499
The pseudocapsule in hepatocellular carcinoma: correlation between dynamic MR imaging and pathologyQ77953205
Characterization of focal liver lesions by ADC measurements using a respiratory triggered diffusion-weighted single-shot echo-planar MR imaging techniqueQ81499168
The uptake transporter OATP8 expression decreases during multistep hepatocarcinogenesis: correlation with gadoxetic acid enhanced MR imagingQ84230646
Diagnostic performance of apparent diffusion coefficient for predicting histological grade of hepatocellular carcinomaQ84554967
Hepatic Hemangioma and Metastasis: Differentiation With Gadoxetate Disodium–Enhanced 3-T MRIQ85063116
P433issue2
P921main subjectintrahepatic cholangiocarcinomaQ18556554
cholangiocarcinomaQ124292
hepatocellular carcinomaQ1148337
P304page(s)96-104
P577publication date2015-03-01
P1433published inDiagnostic and interventional radiology : official journal of the Turkish Society of RadiologyQ26842393
P1476titleDistinguishing intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma using precontrast and gadoxetic acid-enhanced MRI
P478volume21

Reverse relations

cites work (P2860)
Q39259950Added value of smooth hypointense rim in the hepatobiliary phase of gadoxetic acid-enhanced MRI in identifying tumour capsule and diagnosing hepatocellular carcinoma.
Q38684422Capsule, septum, and T2 hyperintense foci for differentiation between large hepatocellular carcinoma (≥5 cm) and intrahepatic cholangiocarcinoma on gadoxetic acid MRI.
Q52982866Differentiation of mass-forming intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma: based on the multivariate analysis of contrast-enhanced computed tomography findings.
Q41074605Identification of Imaging Predictors Discriminating Different Primary Liver Tumours in Patients with Chronic Liver Disease on Gadoxetic Acid-enhanced MRI: a Classification Tree Analysis
Q44796084LI-RADS M (LR-M): definite or probable malignancy, not specific for hepatocellular carcinoma.
Q28075361Recent Advances in the Imaging Diagnosis of Hepatocellular Carcinoma: Value of Gadoxetic Acid-Enhanced MRI

Search more.